Evaluation of clinical and biological prognostic factors in relapsed or refractory diffuse large B-cell lymphoma patients after previous treatment with rituximab and chemotherapy: Results of the PRO-R-IPI study

1. Panizo, C.
2. Rodríguez, A.J.
3. Gutiérrez, G.
4. Díaz, F.J.
5. González-Barca, E.
6. De Oña, R.
7. Grande, C.
8. Sancho, J.M.
9. García-Álvarez, M.F.
10. Sánchez-González, B.
11. Peñalver, F.J.
12. Cannata, J.
13. Espeso, M.
14. Requena, M.J.
15. Gardella, S.
16. Durán, S.
17. González, A.P.
18. Alfonso, A.
19. Caballero, M.D.